Actome GmbH based in Freiburg, an innovative biotech start-up in the field of protein analysis, has managed to secure its business continuation and obtain long-term finance in the course of a structured process to find a new investor. The transaction was accompanied by WINTERGERST Societät für Unternehmer-Beratung. The finance was secured from a consortium of former shareholders and members of management and has secured the continuity of the company for the long term.
The solution means that core competencies, ongoing research projects and the entire workforce and extensive patent portfolio can be retained. This has laid the foundation needed to secure operations for the long term and open up sustainable prospects for the company’s future.